The diverse immunomodulatory properties of mesenchymal stem/stromal cells (MSCs) could be exploited for treatment of a multitude of inflammatory conditions. Nevertheless whether rejection of donor MSCs influences the efficacy of allogeneic MSC therapies is not known and no definitive clinical advantage of autologous MSCs over allogeneic MSCs has been demonstrated to date. Although MSCs may… Continue reading The diverse immunomodulatory properties of mesenchymal stem/stromal cells (MSCs) could be